Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

When the CEO Buys, You Need to Listen

The insiders just keep buying at our "liquid-biopsy" play TrovaGene Inc. (Nasdaq: TROV).

Shares of the San Diego-based company doubled in just three months after we recommended back on March 11.

When the stock sold off after that skyrocket rally, we told you not to worry. In fact, we recommended you turn that weakness into an opportunity - and accumulate more shares.

The corporate insiders seem to share our confident outlook.

Full Story

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK